WS #11072
US House committee opens national security probe into Merck and AbbVie's China drug trials, seeking documents on data protection and potential military applications, creating downside risk for MRK and ABBV.
US House Investigation into Merck and AbbVie China Drug Trials
US House committee opens national security probe into Merck and AbbVie's China drug trials, seeking documents on data protection and potential military applications, creating downside risk for MRK and ABBV.